首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1652092

關節內粘稠補充療法的全球市場:市場規模·佔有率·趨勢，產業分析 (各產品·各最終用途·各地區)，未來預測 (2025年～2034年)

Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region - Market Forecast, 2025-2034

出版日期: 2025年01月01日 | 出版商:

Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據 Polaris Market Research 的一項新研究，全球黏液補充市場預計到 2034 年將達到 152.6 億美元。該報告提供了有關當前市場動態的詳細見解，並對未來市場的成長進行了分析。

由於膝關節骨性關節炎 (OA) 盛行率不斷上升以及對非手術治療方案的需求不斷增加，黏彈性補充劑市場正在經歷顯著增長。黏彈性補充療法是將透明質酸注射到膝關節以緩解疼痛、改善活動能力，並被輕度至中度骨關節炎患者廣泛接受。全球人口老化、關節健康意識的增強、以及單次注射和交聯形式等透明質酸製劑的進步（這些製劑更加方便、有效）使該市場受益。

擴大採用微創替代關節置換手術是推動黏彈性補充市場擴張的主要驅動力之一。歐洲、北美等地區優惠的報銷政策以及新興國家醫療服務可近性的改善進一步推動了市場需求。技術進步和對更有效配方的持續研究正在為現有企業和新進業者創造巨大的市場機會。

黏液補充劑市場有望實現持續的市場成長，領先的公司正在投資創新和策略合作夥伴關係，以滿足不斷變化的患者需求，並利用新機會加強其作為骨關節炎管理不可或缺的一部分的作用。

市場前景樂觀，由於人口老化加劇、可支配收入增加和醫療保健基礎設施改善，亞太地區預計將出現強勁增長。然而，課題依然存在，包括定價壓力、替代療法的競爭和監管障礙。

體內補充劑市場：分析概述

基於產品，三種注射劑型預計將在 2024 年佔據最大的市場佔有率，因為它們在治療膝關節骨性關節炎方面具有明確的療效、廣泛的可用性以及醫療保健提供者的偏好。

根據最終用途，預計骨科診所/ASC 部門將在預測期內以最快的速度增長，這歸因於患者越來越傾向於在這些環境中提供的專業化、經濟高效和微創治療。

由於亞太地區人口老化嚴重且膝關節骨性關節炎盛行率不斷上升，預計到 2024 年，該地區將佔據關節內置換治療市場的最大佔有率。

由於對先進的骨關節炎治療的需求不斷增加，預計歐洲黏彈性補充劑市場將在預測期內實現最快的複合年增長率。

全球領先公司包括 Anika Therapeutics, Inc.、DePuy Synthes、F. Hoffmann-La Roche Ltd.、Ferring Pharmaceuticals BV、Fidia Farmaceutici SpA、LG Life Sciences Ltd.、Lifecore Biomedical、Sanofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Biofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Biofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Biofi、Seikagaku Corporation、Smith & Nephew PLC 和 Zimmer Bio。

主要的分析結果
簡介
- 關節內粘稠補充療法市場評估:各地區 (2020～2034年)
北美
- 北美:各產品 (2020～2034年)
- 北美:各最終用途 (2020～2034年)
- 美國
- 加拿大
歐洲
- 歐洲:各產品 (2020～2034年)
- 歐洲:各最終用途 (2020～2034年)
- 英國
- 法國
- 德國
- 義大利
- 西班牙
- 荷蘭
- 俄羅斯
- 其他歐洲
亞太地區
- 亞太地區:各產品 (2020～2034年)
- 亞太地區:各最終用途 (2020～2034年)
- 中國
- 印度
- 馬來西亞
- 日本
- 印尼
- 韓國
- 澳洲
- 其他亞太地區
中東·非洲
- 中東·非洲:各產品 (2020～2034年)
- 中東·非洲:各最終用途 (2020～2034年)
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
- 其他中東·非洲
南美
- 南美:各產品 (2020～2034年)
- 南美:各最終用途 (2020～2034年)
- 墨西哥
- 巴西
- 阿根廷
- 其他南美國家

第8章競爭情形

事業擴大·企業收購的分析
- 事業擴大
- 企業收購
聯盟/合作/協定/公開

第9章企業簡介

Anika Therapeutics, Inc.
DePuy Synthes
F.Hoffmann-La Roche Ltd.
Ferring Pharmaceuticals B.V.
Fidia Farmaceutici S.p.A
LG Life Sciences Ltd.
Lifecore Biomedical
Sanofi
Seikagaku Corp.
Smith & Nephew PLC
Zimmer Biomet

簡介目錄圖表

Product Code: PM1015

The global viscosupplementation market size is expected to reach USD 15.26 billion by 2034, according to a new study by Polaris Market Research. The report "Viscosupplementation Market Size, Share, Trends, Industry Analysis Report: By Product (Three Injection, Five Injection, and Single Injection), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The viscosupplementation market is experiencing significant growth, driven by the rising prevalence of knee osteoarthritis (OA) and increasing demand for non-surgical treatment options. Viscosupplementation, which involves injecting hyaluronic acid into the knee joint to alleviate pain and improve mobility, has gained widespread acceptance among patients with mild to moderate OA. The market is benefitting from an aging global population, growing awareness of joint health, and advancements in hyaluronic acid formulations, such as single-injection and cross-linked variants, which enhance convenience and efficacy.

The increasing adoption of minimally invasive treatments that offer an alternative to joint replacement surgery is one of the key drivers of the viscosupplementation market expansion. Favorable reimbursement policies in regions like Europe and North America, along with improving healthcare access in emerging economies, have further boosted market demand. Technological advancements and ongoing research into more effective formulations present significant market opportunities for both established players and new entrants.

The viscosupplementation market is poised for sustained market growth, with key players investing in innovation and strategic partnerships to address evolving patient needs and capitalize on emerging opportunities, reinforcing its role as a vital component of osteoarthritis management.

The market outlook is positive, with robust growth expected in Asia Pacific, driven by large elderly populations, rising disposable income, and enhanced healthcare infrastructure. However, challenges such as pricing pressure, competition from alternative treatments, and regulatory hurdles remain.

Key Highlights of Viscosupplementation Market Report

In terms of product, in 2024, the three injection segment accounted for the largest market share due to its established efficacy, widespread availability, and preference among healthcare providers for managing knee osteoarthritis.

Based on end use, the orthopedic clinics/ASCs segment is expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized, cost-effective, and minimally invasive treatments offered in these settings.

In 2024, Asia Pacific accounted for the largest share of the viscosupplementation market due to the region's large aging population and increasing prevalence of knee osteoarthritis.

The Europe viscosupplementation market is expected to witness the fastest CAGR during the forecast period due to increasing demand for advanced osteoarthritis treatments.

A few global key market players include Anika Therapeutics, Inc.; DePuy Synthes; F. Hoffmann-La Roche Ltd.; Ferring Pharmaceuticals B.V.; Fidia Farmaceutici S.p.A, LG Life Sciences Ltd.; Lifecore Biomedical; Sanofi; Seikagaku Corp.; Smith & Nephew PLC; and Zimmer Biomet.

Polaris Market Research has segmented the viscosupplementation market research report on the basis of product, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Three Injection
Five Injection
Single Injection

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Orthopedic Clinics/ASCs
Hospitals

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Vietnam
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Viscosupplementation Market Insights

4.1. Viscosupplementation Market - Market Snapshot
4.2. Viscosupplementation Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Knee Osteoarthritis
  - 4.2.1.2. Growing Aging Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Treatment Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Viscosupplementation Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Viscosupplementation Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
5.3. Three Injection
- 5.3.1. Global Viscosupplementation Market, by Three Injection, by Region, 2020-2034 (USD Billion)
5.4. Five Injection
- 5.4.1. Global Viscosupplementation Market, by Five Injection, by Region, 2020-2034 (USD Billion)
5.5. Single Injection
- 5.5.1. Global Viscosupplementation Market, by Single Injection, by Region, 2020-2034 (USD Billion)

6. Global Viscosupplementation Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
6.3. Orthopedic Clinics/ASCs
- 6.3.1. Global Viscosupplementation Market, by Orthopedic Clinics/ASCs, by Region, 2020-2034 (USD Billion)
6.4. Hospitals
- 6.4.1. Global Viscosupplementation Market, by Hospitals, by Region, 2020-2034 (USD Billion)

7. Global Viscosupplementation Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Viscosupplementation Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Viscosupplementation Market - North America
- 7.3.1. North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Viscosupplementation Market - U.S.
  - 7.3.3.1. U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Viscosupplementation Market - Canada
  - 7.3.4.1. Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.4. Viscosupplementation Market - Europe
- 7.4.1. Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Viscosupplementation Market - UK
  - 7.4.3.1. UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Viscosupplementation Market - France
  - 7.4.4.1. France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Viscosupplementation Market - Germany
  - 7.4.5.1. Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Viscosupplementation Market - Italy
  - 7.4.6.1. Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Viscosupplementation Market - Spain
  - 7.4.7.1. Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Viscosupplementation Market - Netherlands
  - 7.4.8.1. Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Viscosupplementation Market - Russia
  - 7.4.9.1. Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Viscosupplementation Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.5. Viscosupplementation Market - Asia Pacific
- 7.5.1. Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Viscosupplementation Market - China
  - 7.5.3.1. China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Viscosupplementation Market - India
  - 7.5.4.1. India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Viscosupplementation Market - Malaysia
  - 7.5.5.1. Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Viscosupplementation Market - Japan
  - 7.5.6.1. Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Viscosupplementation Market - Indonesia
  - 7.5.7.1. Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Viscosupplementation Market - South Korea
  - 7.5.8.1. South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Viscosupplementation Market - Australia
  - 7.5.9.1. Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Viscosupplementation Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.6. Viscosupplementation Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Viscosupplementation Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Viscosupplementation Market - UAE
  - 7.6.4.1. UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Viscosupplementation Market - Israel
  - 7.6.5.1. Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Viscosupplementation Market - South Africa
  - 7.6.6.1. South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Viscosupplementation Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
7.7. Viscosupplementation Market - Latin America
- 7.7.1. Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Viscosupplementation Market - Mexico
  - 7.7.3.1. Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Viscosupplementation Market - Brazil
  - 7.7.4.1. Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Viscosupplementation Market - Argentina
  - 7.7.5.1. Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
- 7.7.6. Viscosupplementation Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Anika Therapeutics, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. DePuy Synthes
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. F.Hoffmann-La Roche Ltd.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Ferring Pharmaceuticals B.V.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Fidia Farmaceutici S.p.A
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. LG Life Sciences Ltd.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Lifecore Biomedical
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Sanofi
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Seikagaku Corp.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Smith & Nephew PLC
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Zimmer Biomet
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development

簡介目錄圖表

List of Tables:

Table 1 Global Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 2 Global Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 3 North America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 4 North America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 5 U.S.: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 6 U.S.: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 7 Canada: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 8 Canada: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 9 Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 10 Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 11 UK: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 12 UK: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 13 France: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 14 France: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 15 Germany: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 16 Germany: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 17 Italy: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 18 Italy: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 19 Spain: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 20 Spain: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 21 Netherlands: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 22 Netherlands: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 23 Russia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 24 Russia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 25 Rest of Europe: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 26 Rest of Europe: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 27 Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 28 Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 29 China: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 30 China: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 31 India: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 32 India: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 33 Malaysia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 34 Malaysia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 35 Japan: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 36 Japan: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 37 Indonesia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 38 Indonesia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 39 South Korea: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 40 South Korea: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 41 Australia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 42 Australia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 43 Rest of Asia Pacific: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 44 Rest of Asia Pacific: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 45 Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 46 Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 47 Saudi Arabia: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 48 Saudi Arabia: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 49 UAE: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 50 UAE: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 51 Israel: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 52 Israel: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 53 South Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 54 South Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 55 Rest of Middle East & Africa: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 56 Rest of Middle East & Africa: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 57 Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 58 Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 59 Mexico: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 60 Mexico: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 61 Brazil: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 62 Brazil: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 63 Argentina: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 64 Argentina: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)
Table 65 Rest of Latin America: Viscosupplementation Market, by Product, 2020-2034 (USD Billion)
Table 66 Rest of Latin America: Viscosupplementation Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Viscosupplementation Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product
Figure 7. Global Viscosupplementation Market, by Product, 2024 & 2034 (USD Billion)
Figure 8. Market by End Use
Figure 9. Global Viscosupplementation Market, by End Use, 2024 & 2034 (USD Billion)

02-2729-4219

+886-2-2729-4219